Boston Scientific Corporation (BSX) Stock

About Boston Scientific Corporation

Boston Scientific Corporation is led by CEO Michael F. Mahoney, employs 53,000 people, headquartered in Marlborough, US, publicly traded since 1992.

Boston Scientific Corporation (BSX) stock trades at $45.69 with a market capitalization of $66.22B. The stock is valued at a price-to-earnings (P/E) ratio of 17.71, price-to-book of 2.60, price-to-sales of 3.11. Over the past 52 weeks the stock has ranged between $41.44 and $105.65, and currently trades 56.8% below its 52-week high.

On profitability, Boston Scientific Corporation generates a return on equity (ROE) of 14.90%, return on capital employed of 11.62%, an operating margin of 19.78%, a net profit margin of 17.47%.

In its most recent fiscal year, Boston Scientific Corporation reported annual revenue of $20.1B, net profit of $2.9B. Revenue grew at an average annual rate of 15.2% over the last 5 fiscal years.

The balance sheet shows a debt-to-equity ratio of 0.51, a current ratio of 1.62, total assets of $43.7B, $2.0B in cash and equivalents.

BSX has an average daily trading volume of 19,569,174 shares, a beta of 0.57 (historically less volatile than the overall market).

Boston Scientific Corporation by the numbers, 2016–2025

Between 2016 and 2025 Boston Scientific Corporation reported revenue of $8.4B rising to $20.1B, a change of +139.4% across 10 years. Compounded, revenue has grown 15.2% a year over five years, 16.5% over three, 19.9% over the last twelve months. Net profit rose to $2.9B.

Operating margin went from 14.7% in 2016 to 19.8% in 2025, a gain of 5.0 percentage points. The most recent net margin is 17.47%. On a trailing twelve-month basis to Jun '26, revenue is $21.0B and net profit $3.7B.

Borrowings rose from $5.5B to $12.4B, cash from operations was $4.5B in the latest year, positive in 10 of the last 10.

Return on equity has averaged 7.8% over five years, and was 11.9% in the most recent year.

The share price itself has compounded at —% a year over five years, —% over three, —% over the last year. Past price movement is history, not a forecast.

Figures are as reported and in the company's own reporting currency. They describe what has already happened and carry no implication about what follows.

Boston Scientific Corporation (BSX) — frequently asked questions